In Brief: PolyPid’s D-PLEX100 Aces Phase III Trial, US Partner, Submission Eyed

Second Time Lucky

PolyPid announced results from the Phase III study of D-PLEX100 in preventing surgical site infections • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D